Zobrazeno 1 - 10
of 30
pro vyhledávání: '"K. A. Grindulis"'
Publikováno v:
Rheumatology. 45:1309-1312
Haara et al recently published a study assessing epidemiological aspects of osteoarthritis (OA) in Finland.1 A finding of interest was their identification of OA (in any finger joint) as a predictor of cardiovascular death among men, with the authors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a0404aa292927c7ed197b273250f44f
https://europepmc.org/articles/PMC1754517/
https://europepmc.org/articles/PMC1754517/
Publikováno v:
British journal of rheumatology. 31(4)
Clinical and immunological parameters in 14 patients with rheumatoid arthritis (RA) receiving sulphasalazine (SASP) were evaluated, to determine whether their clinical response was reflected by any quantitative changes in their peripheral blood lymph
Publikováno v:
Rheumatology. 47:1838-1838
Publikováno v:
Clinical Science. 80:18P-19P
Publikováno v:
Rheumatology; Oct2006, Vol. 45 Issue 10, p1309-1312, 4p
Publikováno v:
Annals of the Rheumatic Diseases. 43:8-17
A prospective study over one year of patients who had active rheumatoid arthritis discovered 64 who had received treatment for an adequate time with second-line drugs. In these patients there was evidence of continuing joint destruction as shown by r
Publikováno v:
Rheumatology International. 3:39-42
Two methods of assessing changes in hand and wrist radiographs, the Larsen Index and Amos Index, were compared and contrasted in 48 patients with rheumatoid arthritis (RA). X-rays were taken before and after 1 year of treatment with remission-inducin
Autor:
K A Grindulis, Vera Neumann
Publikováno v:
Journal of the Royal Society of Medicine. 77:169-172
Publikováno v:
BMJ. 287:1099-1102
Sulphasalazine was first formulated by Svartz in the early 1940s, specifically for use as a remission inducing drug in rheumatoid arthritis. After the publication of an unfavourable trial, however, the drug was restricted to patients with ulcerative